Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6233370rdf:typepubmed:Citationlld:pubmed
pubmed-article:6233370lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C0020960lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C0026249lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:6233370lifeskim:mentionsumls-concept:C0002131lld:lifeskim
pubmed-article:6233370pubmed:issue1lld:pubmed
pubmed-article:6233370pubmed:dateCreated1984-7-18lld:pubmed
pubmed-article:6233370pubmed:abstractTextThe effects of Ly-5 alloantisera on the generation of cytotoxic T cells (CTL), on the effector phase of CTL killing, and on polyclonal mitogenesis were studied. Ly-5 antisera added at the beginning of mixed lymphocyte culture (MLC) suppressed the production of CTL in an allele-specific manner. Neither Ly-5.1 nor Ly-5.2 antisera inhibited the generation of cytotoxic effectors by Ly-5.1/Ly-5.2 heterozygous spleen cells; however, a combination of Ly-5.1 and Ly-5.2 antisera markedly suppressed the appearance of Ly-5 heterozygous CTL. Similarly, Ly-5 antisera inhibited the effector phase of CTL killing in an allele-specific manner. In addition, Ly-5 alloantisera specifically blocked concanavalin A and oxidative mitogenesis of splenocytes carrying the appropriate Ly-5 alloantigen. The results are discussed in light of a possible functional role of Ly-5 molecules in immune processes.lld:pubmed
pubmed-article:6233370pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:languageenglld:pubmed
pubmed-article:6233370pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6233370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6233370pubmed:statusMEDLINElld:pubmed
pubmed-article:6233370pubmed:monthJullld:pubmed
pubmed-article:6233370pubmed:issn0022-1767lld:pubmed
pubmed-article:6233370pubmed:authorpubmed-author:HareJ FJFlld:pubmed
pubmed-article:6233370pubmed:authorpubmed-author:EwaldS JSJlld:pubmed
pubmed-article:6233370pubmed:authorpubmed-author:DavisB SBSlld:pubmed
pubmed-article:6233370pubmed:issnTypePrintlld:pubmed
pubmed-article:6233370pubmed:volume133lld:pubmed
pubmed-article:6233370pubmed:ownerNLMlld:pubmed
pubmed-article:6233370pubmed:authorsCompleteYlld:pubmed
pubmed-article:6233370pubmed:pagination10-5lld:pubmed
pubmed-article:6233370pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:meshHeadingpubmed-meshheading:6233370-...lld:pubmed
pubmed-article:6233370pubmed:year1984lld:pubmed
pubmed-article:6233370pubmed:articleTitleInhibition of T cell responses to alloantigens and polyclonal mitogens by Ly-5 antisera.lld:pubmed
pubmed-article:6233370pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6233370pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6233370pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
entrez-gene:19264entrezgene:pubmedpubmed-article:6233370lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6233370lld:pubmed